October 3 (SeeNews) - Swiss-based pharmaceutical company Amicus is among the bidders in a tender for the privatisation of Serbian ailing pharmaceutical firm Galenika, Serbian media reported on Tuesday.
As much as two bids for Galenika were placed within the deadline, set on October 2, and one of them was submitted by Amicus, daily Politika reported.
You can subscribe to our M&A newsletter here
The tender commission will check on Wednesday whether the bids meet the requirements of the tender. One of them is that the annual turnover of the bidders is at least 300 million euro ($352.3 million), Politika said.
Last month, Serbia's economy ministry said a total of 10 companies had purchased tender documents for the privatisation of Galenika by the September 20 deadline.
The Serbian government launched the tender for the sale of its 93% stake in Galenika on September 1. The minimum price was set at 25 million euro for the repayment of Galenika's debt plus 1 euro for the tendering.
The remaining 7% stake in the drug maker is held by retail investors.
($=0.851476 euro)